recommend treatment with CYC for life-threatening conditions in the second or third trimester When potentially teratogenic medications are discontinued prior to pregnancy, we strongly recommend a period of observation without medication or transition to pregnancy-compatible medications to ensure disease stability (as discussed above). In women with inadvertent exposure to teratogenic medications we strongly suggest immediate referral to a maternal-fetal medicine specialist, pregnancy medication